Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | CES1 | P23141 | 3/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | FLT4 | P35916 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782806 | 0.68 | NPC1 (0.37) | MAPTL3MBTL1CES2CES1ALOX15 | |
| SCHEMBL7788590 | 0.68 | HTT (0.31) | MAPTL3MBTL1CES2CES1ALOX15 | |
| SCHEMBL8345761 | 0.68 | — | — | |
| SCHEMBL7782761 | 0.67 | L3MBTL1 (0.36) | MAPTL3MBTL1ALOX15TSHR | |
| SCHEMBL7787651 | 0.67 | NPC1 (0.39) | MAPTTP53L3MBTL1CES2CES1 | |
| SCHEMBL2717876 | 0.66 | — | — | |
| SCHEMBL7768283 | 0.64 | — | — | |
| SCHEMBL29067489 | 0.64 | NPC1 (0.41) | MAPTL3MBTL1CES2CES1ALOX15 | |
| SCHEMBL1874394 | 0.63 | MAPT (0.38) | LMNAMAPTL3MBTL1CES2MGLL | |
| SCHEMBL11371672 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395323-B1 | METHOD FOR TREATING HAIR | KAO CORP (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-20190038532-A1 | METHOD FOR TREATING HAIR | KAO CORPORATION (JP) | 2019-02-07 | — | — | US | disclosed |
| EP-3395323-A1 | HAIR TREATMENT METHOD | Kao Corporation (JP) | 2018-10-31 | — | — | EP | disclosed |
| EP-0672405-B1 | Hair treatment composition | KAO CORP (JP) | 2001-11-14 | — | — | EP | disclosed |
| EP-0662314-B1 | Method of hair treatment | KAO CORP (JP) | 1999-11-03 | — | — | EP | disclosed |
| EP-0529437-B1 | Hair treatment composition | KAO CORP (JP) | 1996-07-17 | — | — | EP | disclosed |
| EP-0672405-A1 | Hair treatment composition | KAO CORPORATION (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0662314-A1 | Method of hair treatment | Kao Corporation (JP) | 1995-07-12 | — | — | EP | disclosed |
| EP-0529437-A1 | Hair treatment composition | Kao Corporation (JP) | 1993-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190038532-A1 | METHOD FOR TREATING HAIR | TYR, POLR1C, CA7 | LMNA 2120/4885MAPT 1450/4885TP53 1727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.